OCI Holdings Appoints Lim Ju-hyun, Hanmi Pharm President, as Inside Director
OCI Holdings announced on the 6th that it will appoint Lim Ju-hyun, president of Hanmi Pharm, as a new inside director at the shareholders' meeting to be held on the 29th of this month.
Currently, OCI Group and Hanmi Pharm Group are pursuing a merger, and Lim's appointment as an inside director is a procedural step for the integration process.
Also, Kim Nam-gyu, CEO of the private equity firm La D?fense Partners, which is serving as an advisory role for the integration of the two groups, is expected to join OCI Holdings as an inside director. Kim will serve as the head of the group integration TFT at OCI Holdings.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- Is This the Peak? As Others Hesitate..."The Answer Is Clear for Surviving the KOSPI 10,000 Era"
- "I Take Full Responsibility"... Chung Yongjin Issues Direct Apology for Starbucks 'May 18 Controversy' (Update)
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
Lee Woo-hyun, chairman of OCI Holdings, will also be reappointed as an inside director.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
